25 May 2013
Keywords: genentech, reports, progress, asthma, antibody, e25, reported
Article | 23 September 1997
Genentech has reported encouraging preliminary results from a Phase IItrial testing its recombinant humanized monoclonal antibody against immunoglobulin E, E25, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.